Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zoetis (NY: ZTS )

175.18 -6.77 (-3.72%)
Official Closing Price Updated: 7:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Zoetis

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Wall Street Struggles Ahead Of Election Day, Energy Sector Outperforms, Solar Stocks Rise: What's Driving Markets Monday?
The U.S. stock market struggled to gain momentum on Monday as investors remained cautious ahead of Election Day on Tuesday. 
Via Benzinga
Zoetis Q3 Earnings Beat, Companion Animal Segment Growth Gives Confidence Into 2025: Analyst
Zoetis Inc's Q3 2024 results show a 16% EPS increase and an 11% revenue boost. The company raises its 2024 guidance, highlighting strong global growth in key segments. 
Via Benzinga
Topics Earnings
Exposures Financial
Zoetis (ZTS) Q3 2024 Earnings Call Transcript
ZTS earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Zoetis Barks Up A Third-Quarter Beat And Raise, But Stock Slips
Zoetis stock inched higher Monday after the animal health company beat third-quarter expectations and raised its outlook. 
Via Investor's Business Daily
Here's How Much $1000 Invested In Zoetis 10 Years Ago Would Be Worth Today
Via Benzinga
In-Depth Examination Of 7 Analyst Recommendations For Zoetis
Via Benzinga
$1000 Invested In Zoetis 10 Years Ago Would Be Worth This Much Today
Via Benzinga
'Venture Investing Is Random,' Says Kevin O'Leary. The Craziest Bets, Like Cat DNA Tests, Often Cover All The Losses
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy
FDA approves Elanco's once-daily oral treatment, Zenrelia, for controlling itching in dogs with allergic and atopic dermatitis. The drug, proven effective in studies, faces adoption challenges due to... 
Via Benzinga
Exposures Product Safety
Starbucks To Rally More Than 22%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Where Zoetis Stands With Analysts
Via Benzinga
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years
Via Benzinga
Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today
Via Benzinga
How Is The Market Feeling About Zoetis?
Via Benzinga
Jim Cramer Says This Retailer Yields 3%: 'Which Is Quite Good'
Jim Cramer discusses PROCEPT BioRobotics, Zoetis, Target and Consolidated Edison. " 
Via Benzinga
The Latest Analyst Ratings For Zoetis
Via Benzinga
Here's How Much $100 Invested In Zoetis 10 Years Ago Would Be Worth Today
Via Benzinga
Animal Health Firm Zoetis Clocks Strong Q2 Earnings, Companion Animal Operations Boost Confidence For 2024
Zoetis stock rises as Q2 revenue hits $2.36 billion, up 8% YOY, surpassing estimates. U.S. revenue grew 12%, driven by strong sales of companion animal products like Librela and Solensia. The company... 
Via Benzinga
ZTS Stock Earnings: Zoetis Beats EPS, Beats Revenue for Q2 2024
ZTS stock results show that Zoetis beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Zoetis (ZTS) Q2 2024 Earnings Call Transcript
ZTS earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Why Zoetis Stock Was Moving Higher Tuesday
It was a classic beat-and-raise quarter for Zoetis. 
Via The Motley Fool
Zoetis Earnings Growth Picks Up, Tops Views
The animal drug giant's EPS growth had decelerated in the prior two quarters. 
Via Investor's Business Daily
NYSE:ZTS Shows Potential for a Breakout.
Will ZOETIS INC Break Out? A Technical Analysis Perspective. 
Via Chartmill
Home Depot To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Deep Dive Into Zoetis Stock: Analyst Perspectives (4 Ratings)
Via Benzinga
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years
Via Benzinga
How Is The Market Feeling About Zoetis?
Via Benzinga
The Top 3 Long-Term Stocks to Buy for Decades of Gains
Three long-term stocks to buy for consistent revenue growth and profitability supported by their competitive positions. 
Via InvestorPlace
3 Pet Stocks That Are Better Buys Than Chewy
With all of the publicity surrounding Chewy lately, these pet stocks may be a much better fit for investors. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.